Characterizing Potentially Preventable Cancer- and Chronic Disease–Related Emergency Department Use in the Year After Treatment Initiation: A Regional Study
The DOI matches its Crossref record; 3 of the 3 references it cites were found in a registry or an index.
Abstract
Purpose: As new quality metrics and interventions for potentially preventable emergency department (ED) visits are implemented, we sought to compare methods for evaluating the prevalence and costs of potentially preventable ED visits that were related to cancer and chronic disease among a commercially insured oncology population in the year after treatment initiation. Methods: We linked SEER records in western Washington from 2011 to 2016 with claims from two commercial insurers. The study included patients who were diagnosed with a solid tumor and tracked ED utilization for 1 year after the start of chemotherapy or radiation. Cancer symptoms from the Centers for Medicare & Medicaid Services metric and a patient-reported outcome intervention were labeled potentially preventable (PpCancer). Prevention Quality Indicators of the Agency for Healthcare Research and Quality were labeled potentially preventable–chronic disease (PpChronic). We reported the primary diagnosis, all diagnosis field coding (1 to 10), and 2016 adjusted reimbursements. Results: Of 5,853 eligible patients, 27% had at least one ED visit, which yielded 2,400 total visits. Using primary diagnosis coding, 49.8% of ED visits had a PpCancer diagnosis, whereas 3.2% had a PpChronic diagnosis. Considering all diagnosis fields, 45.0%, 9.4%, and 18.5% included a PpCancer only, a PpChronic only, and both a PpCancer and a PpChronic diagnosis, respectively. The median reimbursement per visit was $735 (interquartile ratio, $194 to $1,549). Conclusion: The prevalence of potentially preventable ED visits was generally high, but varied depending on the diagnosis code fields and the group of codes considered. Future research is needed to understand the complex landscape of potentially preventable ED visits and measures to improve value in cancer care delivery.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Basch, E., Deal, A. M., Dueck, A. C., Scher, H. I., Kris, M. G., Hudis, C., & Schrag, D. (2017) · JAMA · doi:10.1001/jama.2017.7156 · Cited by 2,302
Newcomer, L. N., Gould, B., Page, R. D., Donelan, S. A., & Perkins, M. (2014) · Journal of Oncology Practice · doi:10.1200/jop.2014.001488 · Cited by 128
Kline, R. M., Bazell, C., Smith, E., Schumacher, H., Rajkumar, R., & Conway, P. H. (2015) · Journal of Oncology Practice · doi:10.1200/jop.2014.002337 · Cited by 110
Cited by
Basch, E., Schrag, D., Henson, S., Jansen, J., Ginos, B., Stover, A. M., Carr, P., Spears, P. A., Jonsson, M., Deal, A. M., et al. (2022) · JAMA · doi:10.1001/jama.2022.9265 · Cited by 413
Implementation of Patient-Reported Outcomes in Routine Medical Care
Basch, E., Barbera, L., Kerrigan, C. L., & Velikova, G. (2018) · American Society of Clinical Oncology Educational Book · doi:10.1200/edbk_200383 · Cited by 407
The increasing value of eHealth in the delivery of patient-centred cancer care
Penedo, F. J., Oswald, L. B., Kronenfeld, J. P., Garcia, S. F., Cella, D., & Yanez, B. (2020) · The Lancet Oncology · doi:10.1016/s1470-2045(20)30021-8 · Cited by 252
Basch, E., Stover, A. M., Schrag, D., Chung, A., Jansen, J., Henson, S., Carr, P., Ginos, B., Deal, A., Spears, P. A., et al. (2020) · JCO Clinical Cancer Informatics · doi:10.1200/cci.20.00081 · Cited by 194
Caterino, J. M., Adler, D., Durham, D. D., Yeung, S.-C. J., Hudson, M. F., Bastani, A., Bernstein, S. L., Baugh, C. W., Coyne, C. J., Grudzen, C. R., et al. (2019) · JAMA Network Open · doi:10.1001/jamanetworkopen.2019.0979 · Cited by 164
Self-citation
Metadata
- Authors
- Panattoni, L., Fedorenko, C., Greenwood-Hickman, M. A., Kreizenbeck, K., Walker, J. R., Martins, R., Eaton, K. D., Rieke, J. W., Conklin, T., Smith, B., Lyman, G., & Ramsey, S. D.
- Venue
- Journal of Oncology Practice
- Published
- 2018-03
- Volume
- 14
- Issue
- 3
- Pages
- e176-e185
- ISSN
- 1554-7477 (ISSN-L)
- 1935-469X
- OpenAlex
- W2786835559
- Cited by
- 105
- References
- 3
- FWCI
- 10.95
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.